Procrit Market Report 2026

Procrit Market Overview

• The Procrit market growth in the historic period has been driven by increasing prevalence of chronic kidney disease, rising chemotherapy-induced anemia cases • Market expansion is supported by increasing focus on personalized anemia management, rising adoption of biosimilar alternatives • Growth Driver: Rising Anemia Prevalence Fuels Market Growth • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Procrit Market?

Procrit is a brand name for epoetin alfa, a prescription medication used to treat anemia resulting from various conditions. It is a synthetic form of erythropoietin, a hormone naturally produced by the kidneys that stimulates the bone marrow to produce red blood cells. Procrit is commonly prescribed for anemia associated with chronic kidney disease, anemia caused by chemotherapy in patients with non-myeloid cancers, anemia in patients with HIV or AIDS receiving zidovudine, and anemia in patients scheduled for elective surgery to reduce the need for blood transfusions. The main indications of procrit are chronic kidney diseases, human immunodeficiency virus (HIV) infection, and chemotherapy. Chronic kidney disease is a condition where the kidneys gradually lose their ability to filter waste products from the blood. The distribution channels are direct sales, pharmaceutical wholesalers, and retail pharmacies, and it is used by various end users such as hospitals, outpatient clinics, and home care.

What Is The Procrit Market Growth Forecast?

The growth in the forecast period can be attributed to increasing focus on personalized anemia management, rising adoption of biosimilar alternatives, expansion of chronic disease treatment programs, growing emphasis on patient quality of life, increased investments in biologic drug optimization. Major trends in the forecast period include increasing use of erythropoiesis-stimulating agents, rising demand for anemia management therapies, expansion of oncology supportive care treatments, growing focus on reducing blood transfusions, enhanced monitoring of chronic anemia conditions.

Global Procrit Market Segmentation

1) By Indications: Chronic Kidney Diseases, Human Immunodeficiency Virus (HIV) Infection, Chemotherapy 2) By Distribution Channel: Direct Sales, Pharmaceutical Wholesalers, Retail Pharmacies 3) By End Users: Hospitals, Outpatient Clinics, Home Care

What Are The Drivers Of The Procrit Market?

The increase in the prevalence of anemia is expected to fuel the procrit market going forward. Anemia is a medical condition characterized by a deficiency of healthy red blood cells or hemoglobin, resulting in reduced oxygen delivery to tissues. The prevalence of anemia is rising due to factors such as the increasing global burden of chronic diseases such as kidney failure, cancer, and inflammatory disorders, and poor nutrition leading to deficiencies in iron, vitamin B12, and folate. Procrit (epoetin alfa) is used to treat anemia caused by chronic kidney disease, chemotherapy, or certain treatments for HIV. It works by stimulating the production of red blood cells, reducing the need for blood transfusions in patients with low hemoglobin levels. For instance, in December 2024, according to the National Center for Health Statistics, a US-based government agency, the prevalence of anemia in people age 2 years and older in 2023 increased by 9.3% as compared to 2021. Therefore, the increase in the prevalence of anemia drives the procrit industry. The increase in the prevalence of chronic kidney diseases is expected to propel the procrit market going forward. Chronic kidney disease is a condition where the kidneys gradually lose their ability to filter waste products from the blood. The prevalence of chronic kidney diseases is rising due to factors such as aging populations, obesity, and lifestyle factors coupled with environmental exposures. Procrit (epoetin alfa) is used in patients with chronic kidney disease to treat anemia by stimulating red blood cell production, helping to maintain adequate hemoglobin levels, and reducing the need for blood transfusions. For instance, in June 2023, according to the report published by Kidney Research UK, a UK-based non-profit organization, currently, approximately 7.2 million people in the UK are living with chronic kidney disease, representing over 10% of the population. Of these, 3.25 million are in the advanced stages of the disease, while an additional 3.9 million are in the early stages. By 2033, the number of individuals affected by chronic kidney disease is projected to rise to 7.61 million. Therefore, the increase in the prevalence of chronic kidney diseases drives the procrit industry. The rising incidences of cancer are expected to boost the procrit market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body, which can invade and destroy normal tissues and, if not treated, may lead to death. The incidence of cancer is rising due to factors such as an aging population, increased exposure to risk factors such as smoking, obesity, and environmental pollutants, lifestyle changes, and improved diagnostic capabilities that detect cancers earlier and more accurately. Procrit (epoetin alfa) is used in cancer patients undergoing chemotherapy to treat anemia by increasing red blood cell production, improving energy levels, and reducing the need for blood transfusions. For instance, in August 2024, according to a report published by the Australian Institute of Health and Welfare, an Australian-based national agency for information and statistics on Australia's health and welfare, by 2034, Australia is projected to have approximately 209,000 new cancer diagnoses, a significant increase from the estimated 169,000 cases expected in 2024, reflecting the impact of a growing population and rising cancer rates. Additionally, in 2024, cancer is anticipated to account for about 3 out of every 10 deaths in the country. Therefore, the rising incidences of cancer drive the procrit industry.

Key Players In The Global Procrit Market

Major companies operating in the procrit market are Amgen Inc.

Regional Insights

North America was the largest region in the procrit market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Procrit Market?

The procrit market consists of sales of epoetin alfa injections, pre-filled pens, and monitoring products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Procrit Market Report 2026?

The procrit market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the procrit industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.